Susan L. Hendrix

No ORCID on file · 6 papers in corpus · active 2001-2005

Study types

  • article 5
  • review 1

Condition tags

  • disambig:endometritis 3
  • chronic_pelvic_pain 2
  • infertility 1
article 2005
Predictors of Chronic Pelvic Pain in an Urban Population of Women With Symptoms and Signs of Pelvic Inflammatory Disease
·doi:10.1097/01.olq.0000162361.69041.a5

In Brief Objective: The objective of this study was to assess the risk profile for chronic pelvic pain (CPP) after pelvic inflammatory disease (PID). Study: Multivariate logistic regression was used to assess risk factors for CPP in a longi…

article 2004
Condom Use and the Risk of Recurrent Pelvic Inflammatory Disease, Chronic Pelvic Pain, or Infertility Following an Episode of Pelvic Inflammatory Disease
·doi:10.2105/ajph.94.8.1327

Among 684 sexually active women with pelvic inflammatory disease (PID) followed up for a mean of 35 months, we related contraceptive use to self-reported PID recurrence, chronic pelvic pain, and infertility. Persistent use of condoms during…

article 2003
Endometritis does not predict reproductive morbidity after pelvic inflammatory disease
·doi:10.1067/mob.2003.87
article 2002
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial
·doi:10.1067/mob.2002.121625
article 2001
Clinical Predictors of Endometritis in Women With Symptoms and Signs of Pelvic Inflammatory Disease
·doi:10.1097/00006254-200108000-00014

Peipert, Jeffrey T.; Ness, Roberta B.; Blume, Jeffrey; Soper, David E.; Holley, Robert; Randall, Hugh; Sweet, Richard L.; Sondheimer, Steven J.; Hendrix, Susan L.; Amortegui, Antonio; Trucco, Giuliana; Bass, Debra C. for the Pelvic Inflamma…

review 2001
Effect of Selective Estrogen Receptor Modulators on Reproductive Tissues Other Than Endometrium
·doi:10.1111/j.1749-6632.2001.tb04028.x

The objective of this paper is to review the published and unpublished knowledge of the effect of selective estrogen receptor modulators on reproductive tissues other than endometrium. Pharmaceutical companies developing or marketing select…